Article in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Ai TakahashiLaboratory of Pharmacology, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi-shi 274-8555, Chiba, Japan.
Hiroko MiyagishiLaboratory of Pharmacology, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi-shi 274-8555, Chiba, Japan.ORCID 0000-0002-3909-867X
Komugi TsurutaLaboratory of Pharmacology, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi-shi 274-8555, Chiba, Japan.ORCID 0009-0001-9920-7874
Hiroshi NangoLaboratory of Pharmacology, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi-shi 274-8555, Chiba, Japan.ORCID 0000-0002-8271-9937
Dai HiroseLaboratory of Medical Microbiology, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi-shi 274-8555, Chiba, Japan.
Yuri AonoDepartment of Pharmacology, School of Dentistry at Matsudo, Nihon University, 2-870-1 Sakaechonishi, Matsudo-shi 271-8587, Chiba, Japan.ORCID 0000-0002-1867-2150
Minoru TanigawaDepartment of Materials and Applied Chemistry, College of Science and Technology, Nihon University, Building No. 2, 1-5-1 Kanda Surugadai, Chiyoda, Tokyo 101-0062, Japan.
Katsushi NishimuraDepartment of Science and Manufacturing Technology, Junior College, Nihon University, 7-24-1 Narashinodai, Funabashi-shi 274-8501, Chiba, Japan.
Minoru SaitoDepartment of Biosciences, College of Humanities and Sciences, Nihon University, 3-25-40 Sakurajosui, Setagaya-ku, Tokyo 156-8550, Japan.ORCID 0000-0002-0249-7773
Takayuki KawatoDepartment of Oral Health Sciences, Nihon University School of Dentistry, 1-8-13 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-8310, Japan.ORCID 0000-0001-9831-9455
Tadashi SaigusaDepartment of Pharmacology, School of Dentistry at Matsudo, Nihon University, 2-870-1 Sakaechonishi, Matsudo-shi 271-8587, Chiba, Japan.ORCID 0000-0001-6325-9616
Yasuhiro KosugeLaboratory of Pharmacology, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi-shi 274-8555, Chiba, Japan.ORCID 0000-0002-7513-5132
Funding
a grant to encourage and promote research projects at the School of Pharmacy, Nihon University 2024a Nihon University Research Grant #22Dokusen11Japan Society for the Promotion of Science 24K14758Tsuchiya Cultural Foundation 2024-2025
6 · The paper itself
Abstract
Neuropathic pain, characterized by chronic allodynia, remains difficult to manage with current pharmacotherapies. Microglial activation plays a pivotal role in the development and maintenance of neuropathic pain and represents a promising therapeutic target. We previously demonstrated that Miyako
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.